CHGA and neuroendocrine neoplasm: Chromogranin A, a protein secreted by neuroendocrine cells, is a commonly used biomarker in patients with neuroendocrine tumors and can be obtained at diagnosis or in follow up of patients with resected or metastatic disease [1].